Effects of unilateral 6-OHDA lesions on [ 3H]-N- propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat

Neurochemistry International

Volumn 58, Issue 3, 2011, Pages 243-247

  Palner, Mikael ^a   Kjaerby, Celia ^a   Knudsen, Gitte M ^a   Cumming, Paul ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

6 OHDA; 3H NPA; 3H raclopride; Amphetamine; Dopamine D 2 receptor; Dopamine lesion

Indexed keywords

AMPHETAMINE; DOPAMINE; PROPYLNORAPOMORPHINE; PROPYLNORAPOMORPHINE H 3; RACLOPRIDE C 11; RACLOPRIDE H 3; RADIOPHARMACEUTICAL AGENT; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; BRAIN ASYMMETRY; CORPUS STRIATUM; DENERVATION; DOPAMINE RELEASE; DRUG BINDING SITE; EVOKED RESPONSE; EX VIVO STUDY; IN VITRO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; APOMORPHINE; BINDING, COMPETITIVE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

PARKINSONIA; RATTUS;

EID: 79951580881     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.12.007     Document Type: Article

References (16)

1. 11C]-(+)-PHNO in drug-naive Parkinson's disease Brain 132 5 2009 1366 1375
2. J.L. Cadet, R. Last, V. Kostic, S. Przedborski, and V. Jackson-Lewis Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen Brain Research Bulletin 26 5 1991 707 713
3. 3H]propyl- norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein Journal of Cerebral Blood Flow and Metabolism 22 5 2002 596 604 (Pubitemid 34477781)
4. 11C]raclopride PET study Movement Disorders 14 6 1999 1025 1030
5. 11C]raclopride Synapse 44 3 2002 198 202 (Pubitemid 34303918)
6. 3H]N-n-propylnorapomorphine binding sites Neuroscience Letters 57 1 1985 7 12 (Pubitemid 15014797)
7. M. Inaji, T. Okauchi, K. Ando, J. Maeda, Y. Nagai, T. Yoshizaki, H. Okano, T. Nariai, K. Ohno, S. Obayashi, M. Higuchi, and T. Suhara Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats Brain Research 1064 1-2 2005 136 145 (Pubitemid 41774653)
8. 18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats Neurodegenerative Diseases 1 2-3 2004 109 112 (Pubitemid 39369424)
9. K.M. Koochesfahani, R. de la Fuente-Fernández, V. Sossi, M. Schulzer, L.N. Yatham, T.J. Ruth, S. Blinder, and A.J. Stoessl Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies Movement Disorders 21 7 2006 970 975 (Pubitemid 44184598)
10. 2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action Brain Research 502 2 1989 223 232 (Pubitemid 19276508)
11. M. Laruelle Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review Journal of Cerebral Blood Flow and Metabolism 20 2000 423 451 (Pubitemid 30164887)
12. 11C]beta-CFT Nuclear Medicine and Biology 36 8 2009 941 947
13. 2 agonists and antagonists ex vivo Nuclear Medicine and Biology 35 1 2008 11 17 (Pubitemid 350298245)
14. 2/3 receptors in rat brain: a quantitative autoradiographic study Neurochemistry International 56 6-7 2010 747 752
15. 11C]raclopride in baboons Journal of Pharmacology and Experimental Therapeutics 315 1 2005 80 90 (Pubitemid 41380500)
16. J.F. Van der Werf, J.B. Sebens, and J. Korf In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication European Journal of Pharmacology 102 2 1984 251 259 (Pubitemid 14096226)